New $30 million manufacturing facility in Burlington, Ontario, will allow company to manage R&D in-house and scale production without reliance on third-party manufacturers
Novartis and Sandoz already have some experience with the medical marijuana industry, having struck a deal last year to distribute products for a Canadian company that sells medical cannabis products in its home country and in Europe.